Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000478997 | SCV000570058 | uncertain significance | not provided | 2016-04-20 | criteria provided, single submitter | clinical testing | This variant is denoted ATM c.8631G>A at the DNA level. This variant is silent at the coding level, preserving a Leucine at codon 2877. It is not predicted to affect splicing. ATM c.8631G>A was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, suggesting it is not a common benign variant in these populations. The nucleotide which is altered is conserved in mammals. Based on currently available information, it is unclear whether ATM c.8631G>A is a pathogenic or benign variant. We consider it to be a variant of uncertain significance. |
Ambry Genetics | RCV002446930 | SCV002682478 | likely benign | Hereditary cancer-predisposing syndrome | 2020-10-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000478997 | SCV004133278 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | ATM: PM2:Supporting, BP4, BP7 |
Labcorp Genetics |
RCV003605625 | SCV004509418 | likely benign | Ataxia-telangiectasia syndrome | 2023-03-31 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004591425 | SCV005083164 | benign | Familial cancer of breast | 2024-06-20 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |